Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2020 Earnings Conference Call August 5, 2020 4:30 PM ET Company Participants Alex Dasalla - Head, IR Joseph Ciaffoni - President, CEO & Director Paul Brannelly - EVP & CFO Scott Dreyer - EVP & Chief Commercial Officer Conference Call Participants David Steinberg - Jefferies Gregory Gilbert - Truist Securities Serge Belanger - Needham & Company Brandon Folkes - Cantor Fitzgerald & Co. Dana Flanders - Guggenheim Securities David Amsellem - Piper Sandler & Co. Op ...